Pramipexole Dihydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 24 USDMF, 18 CEP/COS, 2 JDMF, 17 EU WC, 11 KDMF, 11 NDC API, 26 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

INTERMEDIATES

10 Intermediate Suppliers

10 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

838 FDF Dossiers, 181 FDA Orange Book, 475 Europe, 33 Canada, 56 Australia, 29 South Africa, 64 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 17 SPI Pharma, 9 DKSH, 1 Pharm-RX Chemical, 6 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Kirsch Pharma, 1 ACG Worldwide, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 10 BASF, 1 CD Formulation, 16 Corel Pharma Chem, 2 DFE Pharma, 7 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 11 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 5 Lubrizol Life Science Health, 11 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 40 Coating Systems & Additives, 34 Thickeners and Stabilizers, 26 Direct Compression, 24 Controlled & Modified Release, 22 Taste Masking, 22 Solubilizers, 18 Chewable & Orodispersible Aids, 18 Granulation, 15 Co-Processed Excipients, 14 Lubricants & Glidants, 13 Disintegrants & Superdisintegrants, 9 Topical, 8 Parenteral, 8 Film Formers & Plasticizers, 7 Rheology Modifiers, 7 API Stability Enhancers, 5 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents

DIGITAL CONTENT

20 News #PharmaBuzz

20 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 153 Regulatory FDF Prices

MARKET PLACE

10 APIs

10 APIs

PATENTS & EXCLUSIVITIES

14 US Patents, 15 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 16 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20667 / DOSAGE - TABLET;ORAL - 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
pramipexole dihydrochloride(UNII: 3D867NP06J) (pramipexole - UNII:83619PEU5T)	pramipexole dihydrochloride	0.250mg

Inactive Ingredients

Ingredient Name	Boehringer Ingelheim Pharmaceuticals, Inc.	Cardinal Health	Lake Erie Medical DBA Quality Care Products LLC
MAGNESIUM STEARATE(70097M6I30)
mannitol(3OWL53L36A)
POVIDONE(FZ989GH94E)
POVIDONES(FZ989GH94E)
silicon dioxide(ETJ7Z6XBU4)
starch, corn(O8232NY3SJ)

Setid 96a79b8f A749 4668 96c5 60c487942621 Applno 20667 Form Tablet Oral Dosage 0 5mg - Drug Product Composition: Pramipexole Dihydrochloride